funding

Neuralink rival Precision raises $102m, and other financings
Pharmaphorum
Fri, 12/20/24 - 11:09 am
Precision Neurosciences
funding
Neuralink
brain-computer interfaces
Former Seagen CEO's biotech raises $140M series A to ready PD1/VEGFR2 antibody for clinic
Fierce Biotech
Thu, 12/19/24 - 11:29 am
Seagen
Ottimo Pharma
funding
Assembly Biosciences Announces $30.1 Million Equity Investment and Accelerated Funding from Gilead to Advance Clinical Development Programs
BioSpace
Thu, 12/19/24 - 11:27 am
Gilead Sciences
Assembly Bio
funding
hepatitis D
Atlas doubles down on ‘disciplined’ biotech investing with latest fundraise
BioPharma Dive
Thu, 12/5/24 - 04:11 pm
Atlas Ventures
funding
biotech
Nuvig pulls in $161M to make better immune drugs
BioPharma Dive
Thu, 12/5/24 - 11:11 am
Nuvig
funding
immune drugs
Maze Therapeutics Raises $115M in Series D Financing
FinSMEs
Tue, 12/3/24 - 11:31 am
Maze Therapeutics
funding
Novo Holdings-backed Adcendo secures $135M for ADC pipeline
Fierce Biotech
Mon, 11/25/24 - 11:10 am
Novo Holdings
Adcendo
funding
antibody-drug conjugate
Fledgling Obesity Biotech Metsera Raises Another $215M for Long-Acting GLP-1
BioSpace
Wed, 11/13/24 - 11:20 am
Metsera
funding
obesity
TRex Bio raises $84M to compete in crowded immune drug field
BioPharma Dive
Wed, 11/13/24 - 10:51 am
TRex Bio
funding
eczema
Disc Medicine secures $200m financing to support trials
Clinical Trials Arena
Mon, 11/11/24 - 11:30 am
Disc Medicine
funding
bitopertin
clinical trials
Neurogene secures $200M ahead of anticipated study readout
BioPharma Dive
Mon, 11/4/24 - 06:55 pm
Neurogene
funding
Rett Syndrome
NGN-401
Blue Earth Therapeutics Ltd announces completion of $76.5M Series A financing to accelerate development of next generation targeted radioligand therapies
PR Newswire
Wed, 10/30/24 - 11:52 am
Blue Earth Therapeutics
funding
radioligands
A new biotech, built around protein design, springs from David Baker’s lab
BioPharma Dive
Wed, 10/30/24 - 11:45 am
Archon Biosciences
David Baker
funding
protein design
Sanofi-backed Agomab raises $89m to advance fibrotic disease treatments
Pharmaceutical Technology
Fri, 10/25/24 - 11:08 am
AgomAb
Sanofi
Invus
funding
fibrotic disease
As new Alzheimer’s biomarkers come into play, here’s where the money is going
Pharma Voice
Thu, 10/17/24 - 09:20 am
R&D
funding
Alzheimer's disease
KdT Ventures Announces Oversubscribed Fund IV to Invest in Early-Stage Frontier Science Companies
Businesswire
Wed, 10/16/24 - 05:24 pm
KdT Ventures
funding
life sciences
Forbion follows string of startup exits with $2.2B fundraise
BioPharma Dive
Wed, 10/16/24 - 12:27 pm
Forbion
startups
funding
life sciences
Novo Holdings-backed Booster takes off with protein degraders aimed at neurodegeneration
Fierce Biotech
Thu, 10/10/24 - 11:21 am
Booster Therapeutics
funding
targeted protein degradation
Novo Holdings
Startup led by John Maraganore raises $135M to build ‘future of RNAi’
BioPharma Dive
Tue, 10/8/24 - 09:50 pm
City Therapeutics
funding
RNAi
John Maraganore
Judo Bio debuts with $100M and a plan to take RNA drugs to the kidney
BioPharma Dive
Mon, 10/7/24 - 11:18 am
Jude Bio
RNA
ligand-siRNA
funding

Pages